P 
510
+0.99%
Close of 9 Nov 2026, in IDR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in IDR, from our data supplier.
Revenue
IDR 360.84bn
FY2021FY2025
Net income
IDR 22.94bn
FY2021FY2025
Free cash flow
−IDR 81.28bn
FY2021FY2025
Shareholders' equity
IDR 368.18bn
FY2021FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | IDR 360.84bn | IDR 541.18bn | IDR 600.00bn | IDR 440.04bn | IDR 453.38bn |
| Gross profit | IDR 22.31bn | IDR 48.90bn | IDR 55.22bn | IDR 37.71bn | IDR 35.62bn |
| Research and development | — | — | IDR 795.7m | IDR 736.9m | IDR 762.3m |
| Operating income | IDR 6.13bn | IDR 33.00bn | IDR 33.27bn | IDR 13.64bn | IDR 12.83bn |
| Net income | IDR 22.94bn | IDR 27.06bn | IDR 25.82bn | IDR 9.78bn | IDR 9.36bn |
| Diluted earnings per share | 5.58 | 6.58 | 6.28 | 2.38 | 2.28 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Total assets | IDR 416.11bn | IDR 471.02bn | IDR 317.07bn | IDR 123.51bn | IDR 120.88bn |
| Cash and short-term investments | IDR 10.11bn | IDR 110.23bn | IDR 64.06bn | IDR 27.45bn | IDR 32.43bn |
| Total liabilities | IDR 47.93bn | IDR 115.55bn | IDR 128.08bn | IDR 70.89bn | IDR 78.14bn |
| Debt | — | — | IDR 22.00bn | — | — |
| Shareholders' equity | IDR 368.18bn | IDR 355.46bn | IDR 188.99bn | IDR 52.62bn | IDR 42.74bn |
| Shares outstanding | 4,113m | 4,113m | 4,113m | 4,113m | 4,113m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Cash from operations | −IDR 75.67bn | −IDR 64.09bn | IDR 14.84bn | −IDR 3.97bn | IDR 16.00bn |
| Capital spending | −IDR 5.60bn | −IDR 13.87bn | −IDR 1.37bn | −IDR 1.01bn | −IDR 2.08bn |
| Free cash flow | −IDR 81.28bn | −IDR 77.97bn | IDR 13.47bn | −IDR 4.98bn | IDR 13.93bn |
| Dividends paid | — | −IDR 15.00bn | — | — | −IDR 10.00bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | IDR 81.98bn | IDR 93.58bn | IDR 99.57bn | IDR 123.79bn | IDR 53.81bn | IDR 83.67bn | IDR 183.32bn | IDR 131.07bn |
| Gross profit | −IDR 398.6m | IDR 10.71bn | IDR 4.74bn | IDR 9.85bn | IDR 5.13bn | IDR 3.10bn | IDR 11.78bn | IDR 16.63bn |
| Operating income | −IDR 3.67bn | IDR 7.31bn | IDR 122.4m | IDR 9.81bn | IDR 903.8m | IDR 4.30bn | IDR 11.43bn | IDR 6.32bn |
| Net income | IDR 1.33bn | IDR 6.12bn | IDR 9.24bn | IDR 7.78bn | IDR 1.50bn | IDR 4.43bn | IDR 9.56bn | IDR 5.63bn |
| Diluted earnings per share | 0.32 | 1.49 | 2.25 | 1.89 | 0.36 | 1.08 | 2.33 | 1.37 |
| Cash from operations | — | — | −IDR 75.67bn | −IDR 49.62bn | −IDR 41.87bn | IDR 273.0m | −IDR 14.96bn | — |
| Capital spending | −IDR 31.16bn | −IDR 647.0m | −IDR 5.60bn | −IDR 2.07bn | −IDR 1.27bn | −IDR 1.61bn | −IDR 13.31bn | — |
| Free cash flow | — | — | −IDR 81.28bn | −IDR 51.69bn | −IDR 43.14bn | −IDR 1.34bn | −IDR 28.27bn | — |
| Total assets | IDR 426.88bn | IDR 408.05bn | IDR 416.11bn | IDR 411.64bn | IDR 406.50bn | IDR 407.50bn | IDR 471.02bn | IDR 450.26bn |
| Cash and short-term investments | IDR 12.65bn | IDR 22.14bn | IDR 10.11bn | IDR 59.70bn | IDR 68.25bn | IDR 108.89bn | IDR 110.23bn | IDR 138.41bn |
| Debt | — | — | — | IDR 1.10bn | — | — | — | — |
| Shareholders' equity | IDR 380.12bn | IDR 374.02bn | IDR 368.18bn | IDR 367.60bn | IDR 352.97bn | IDR 352.46bn | IDR 355.46bn | IDR 375.30bn |
Financial ratios
Data as of 29 Aug 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Gross margin | 6.2% | 9.0% | 9.2% | 8.6% | 7.9% |
| Operating margin | 1.7% | 6.1% | 5.5% | 3.1% | 2.8% |
| Net margin | 6.4% | 5.0% | 4.3% | 2.2% | 2.1% |
| Return on equity | 6.2% | 7.6% | 13.7% | 18.6% | 21.9% |
| Return on assets | 5.5% | 5.7% | 8.1% | 7.9% | 7.7% |
| Free cash flow yield | -2.5% | -1.8% | 0.6% | — | — |
| Revenue growth | -33.3% | -9.8% | 36.3% | -2.9% | — |
| Earnings growth | -15.2% | 4.8% | 164.2% | 4.4% | — |
| Current ratio | 7.15x | 3.21x | 1.63x | 1.75x | 1.52x |
| Debt to equity | 0.00x | 0.00x | 0.12x | — | — |
| Equity ratio | 88.5% | 75.5% | 59.6% | 42.6% | 35.4% |
| Interest coverage | 56.04x | 103.28x | 2304.26x | 63294.74x | — |
| R&D as a share of sales | — | — | 0.1% | 0.2% | 0.2% |
| Buybacks as a share of market value | 0.0% | 0.0% | — | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -6.4% | — | — |
| Operating income | -23.4% | — | — |
| Net income | 32.9% | — | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 7.9% | 8.5% | — | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | |
|---|---|---|
| Price to earnings | 62.0 | 61.1 |
| Price to sales | 3.9 | 3.0 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.